About
Dr Tom Longworth
MB, FACSEP, PGDipSEM
Dr Tom Longworth became a Fellow of the Australasian College of Sports and Exercise Physicians in 2021 after five years of specialist training. He completed his medical degree with the University of Newcastle in 2010 and has had 5 years of experience in emergency and intensive care medicine across Australia since graduating. He has gained a post graduate Diploma in Sports Medicine from the University of Bath in 2018. Tom was awarded the ACSEP college medal for his performance in the Fellowship exams in 2020.
Tom has a wide variety of experience working with elite sports and athletes. He is currently Chief Medical
Officer at The Sydney Roosters Rugby League Club and Head Doctor of the World Champion Jillaroos (Australian Women’s Rugby League Team). Prior sports coverage includes the Sydney 7s rugby union, Australian school boy rugby union, Bledisloe Cup, A-League soccer and National Rowing regattas, as well as voluntary work abroad with the Surfing Doctors’ Association.
Tom has an interest in a wide variety of sport and exercise related medical disorders and acute injuries. He has experience in the use of extracorporeal shockwave therapy, ultrasound guided cortisone injections and platelet rich plasma (PRP) injections.
Elite Sports Coverage
2020 - Current
2017 - Current
2017 - 2019
2017 - 2018
2018
2018
2017
2016
2016
2016
Sydney Roosters Chief Medical Officer
Jillaroos Chief Medical Officer
Sydney Roosters Assistant Medical Officer
Sydney FC National Youth League Doctor
Vissla Manly Pro QS surfing event coverage
Inaugural Sydney Roosters NRLW Team Doctor
Bledisloe Cup Match Day Doctor
West Tigers NSW Cup Team Doctor
Balmain Juniors Club Doctor
Olympic Qualifier Rowing Regatta
Research Publications
Longworth T, McDonald A, Cunningham C, et al. Do rugby league players under-report concussion symptoms? A cross-sectional study of elite teams based in Australia. BMJ Open Sport & Exercise Medicine 2021;7:e000860. doi: 10.1136/bmjsem-2020-000860
Kuah, D., Sivell, S., Longworth, T. et al. Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study. J Transl Med 16, 49 (2018). doi: 10.1186/s12967-018-1420